Edit

Leyden Labs

https://leydenlabs.com/

Last activity: 03.09.2026

Active

Categories: BiotechHealthcareLifeSciencesPharmaVaccines

Leyden Labs helps people live freely by developing products that protect from known and new respiratory viruses.

Mentions

Location: Netherlands

Total raised: $417.78M

Twitter

Youtube

Investors 2

Date	Name	Website
-	F-Prime Ca...	fprimecapi...
12.05.2021	GV	gv.com

Funding Rounds 6

Date	Series	Amount	Investors
26.06.2026	-	$45.59M	European I...
17.10.2025	-	$35.08M	Invest-NL
04.06.2025	-	$20M	European I...
09.01.2025	-	$70M	-
25.01.2022	Series B	$200M	GV
29.03.2021	Series A	$47.11M	-

Mentions in press and media 24

Date	Title	Description
03.09.2026	The Netherlands' top-funded tech companies in H1 2026	Dutch tech companies raised approximately €1.9 billion in H1 2026, with funding concentrated among the largest deals. The three largest rounds alone accounted for approximately 44 per cent of the total, while six companies raised more than ...
11.08.2026	ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer	ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella pertussis, today announced the appointments of Jim Wassil, currently Chief Operating Off...
29.06.2026	European tech weekly recap: €2.1B in deals and Tech.eu Funding Explorer	Last week, we tracked more than 75 tech funding deals worth over €2.1 million and over 5 exits, M&A transactions, rumours, and related news stories across Europe. 📊 The top three industries that raised the most were fintech (€502.9 mill...
26.06.2026	Leyden Labs Raises €40 Million To Advance Respiratory Virus Protection Platform	Leyden Labs announced a €40 million investment to advance its mission of improving protection against influenza and other respiratory viruses. The financing includes participation from the European Innovation Council Fund, Invest-NL, Gates ...
18.10.2025	Leyden Labs Secures €30M for Groundbreaking Respiratory Nasal Spray	Leyden Laboratories, a Dutch biotechnology pioneer, recently secured a significant €30 million in equity funding. The European Innovation Council (EIC) Fund and Invest-NL spearheaded this investment. This crucial capital injection will prop...
17.10.2025	Leyden Labs: €30 Million Secured From EIC And Invest-NL	Dutch biotechnology company Leyden Laboratories B.V. has secured €30 million in new equity financing from the European Innovation Council (EIC) Fund and Invest-NL. The investment will accelerate the clinical development of the company’s pan...
03.10.2025	Leyden Laboratories Raises €30M in Equity Funding	Leyden Laboratories, a Leiden, the Netherlands-based biotechnology company developing nasal sprays, raised €30M in equity funding. The round was led by European Innovation Council (EIC) Fund and Invest-NL. The company intends to use the fun...
08.08.2025	Swiss VC investment in H1 reflects global trends	The market research and analytics firm CB Insights recently published its quarterly State of Venture report, analyzing startup ecosystem developments across the globe. A comparison with the H1 Update of the Swiss Venture Capital Report rev...
04.06.2025	Leyden Labs Receives $20M in Financing from EIB	Leyden Labs, a Leiden, the Netherlands-based clinical-stage biotechnology company, received $20M in financing. The round was led by the European Investment Bank (EIB). The company intends to use the funds to expand operations and its R&...
22.01.2025	CoV Biotechnology Takes Next Step to Become Leyden Labs Asia	Advancing its Mission to Combat Respiratory Infectious Diseases SINGAPORE, SINGPORE, SINGAPORE, January 22, 2025 /EINPresswire.com/ -- - CoV Biotechnology has been acquired by Leyden Labs and continues as Leyden Labs Asia on the global biot...
09.01.2025	Leyden Labs Raises $70M in Funding	Leyden Labs, a Leiden, the Netherlands-based provider of a mucosal protection platform, raised $70M in funding. The round was led by ClavystBio and Polaris Partners with participation from Qiming Venture Partners and continued backing from ...
30.12.2022	Dutch-based biotech and life sciences startups that raised funding in 2022	The Netherlands is swiftly rising to the top as a hub for healthcare and life sciences innovation. More and more Dutch startups are engaged in a range of cutting-edge initiatives, such as the creation of digital health tools, the developmen...
17.11.2022	10 Dutch startups that raised big funding rounds this year and are hiring now	The Netherlands is well-known for its large and successful startups, such as Adyen, Booking.com, and TomTom. And in recent years, there has been a surge in the number of smaller Dutch startups making a name for themselves. The Netherlands h...
31.03.2022	Meet the Amsterdam-based startups that raised funding in Q1 2022; 31 of them are hiring right now	Dutch startups and scale-ups saw significant growth in investments during the past year. According to a report from DSA (Dutch Startup Association), this trend is likely to continue in 2022, with foreign investors showing a lot of interest ...
27.01.2022	Biotech startup Leyden Labs bags $140M Series B	Amsterdam-based Leyden Labs, a creator of products that protect against known and new respiratory viruses, has raised a $140 million round led by Casdin Capital and GV. The funds will be used to support the development of nasal sprays that ...
25.01.2022	Amsterdam’s Leyden Labs raises €124.17M to offer protection from known and new viruses, new variants	Amsterdam-based Leyden Laboratories, a company that aims to protect against a broad range of viruses, announced on Tuesday that it has raised $140M (approx €124.17M) in its Series B round of funding. In March 2021, the company had raised €4...
25.01.2022	Leyden Labs Raises $200M in 2021 for a New Approach to Combat Viruses	--$140M Series B financing led by Casdin Capital and GV (formerly Google Ventures) with participation from leading global life science investors -- -- Proceeds accelerate development of products against a broad range of respiratory viruses ...
25.01.2022	Leyden Laboratories Closes $140M Series B Financing	Leyden Laboratories B.V., an Amsterdam, The Netherlands-based company developing products that protect from known and new respiratory viruses, closed a $140M Series B financing, bringing its total capital raised to approximately $200M in 20...
25.01.2022	Following Janssen flu deal, Leyden Labs gets $140M led by Casdin Capital and GV	Fresh off a licensing deal that gives Leyden Labs a key building block for a medication that provides broad protection against influenza, the biotech unveiled $140 million to advance that product candidate and others in development as nasal...
29.03.2021	Amsterdam-based Leyden Labs raises €40M to develop intranasal products against coronaviruses	Amsterdam-based Leyden Laboratories, a company that aims to protect against a broad range of viruses, has raised €40M in its Series A round of funding led by GV (formerly Google Ventures), with participation from F-Prime Capital, Casdin Cap...
25.03.2021	Leyden Labs Secures €40M in Series A Funding	Leyden Laboratories B.V., an Amsterdam, The Netherlands-based company targeting commonalities of viral families to protect humanity from known and future viruses, closed a €40M Series A financing. The round was led by GV (formerly Google Ve...
25.03.2021	Leyden Labs to Unlock a New Generation of Preventative Medicines against Known and Future Viruses by Securing a €40 Million Series A from GV (formerly Google Ventures), F-Prime and Casdin Capital	-
-	Following Janssen flu deal, Leyden Labs gets $140M led by Casdin Capital and GV	Fresh off a licensing deal that gives Leyden Labs a key building block for a medication that provides broad protection against influenza, the biotech unveiled $140 million to advance that product candidate and others in development as nasal...
-	Leyden Labs	“Leyden Labs helps people live freely by developing products that protect from known and new respiratory viruses.”

Leyden Labs

Investors 2

Funding Rounds 6

Mentions in press and media 24

Reviews 0